RZLT
RezoluteยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RZLT Profile
Rezolute, Inc.
A clinical-stage biopharmaceutical company that develops drug therapies for the treatment of metabolic diseaes
275 Shoreline Drive, Suite 500, Redwood City, California 94065
--
Rezolute, Inc., was incorporated in Delaware in 2010 and re-incorporated in Nevada in June 2021. The Company is an advanced rare disease company focused on significantly improving the prognosis of patients with hypoglycemia caused by hyperinsulinemia (" HI "). The company's main clinical asset, ersodetug, is a potential treatment for hypoglycemia caused by many forms of hyperinsulinemia.
